Waters Corp (WAT)

Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell

$139.70

Buy

$365.00

arrow-down$-3.54 (-1.00%)

Waters Corp is an analytical instrument manufacturer. It designs, manufactures, sells and services liquid chromatography, ultra performance liquid chromatography & mass spectrometry instrument systems & support products.
Prices updated at 30 May 2025, 21:22 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.01%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Dr. Flemming Ornskov
CEO
Dr. Udit Batra, PhD
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
7,600
Head office
34 Maple Street
Milford
United States
01757
mobile
+1 508 478-2000
letter
investor_relations@waters.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Christopher A. Kuebler
Independent Director
0.11m--0.33m-
Ms. Linda Baddour
Independent Director
0.12m--0.34m-
Mr. Richard H. Fearon
Independent Director
0.10m--0.32m-
Dr. Flemming Ornskov
Chairman of the Board
0.26m--0.48m-
Mr. Mark P. Vergnano
Independent Director
0.10m--0.32m-
Mr. Daniel J. Brennan
Independent Director
0.10m--0.32m-
Mr. Wei Jiang
Independent Director
0.09m--0.31m-
Mr. Amol Chaubal
Senior Vice President, Chief Financial Officer and Principal Accounting Officer
0.57m--3.16m-
Dr. Udit Batra, PhD
Director, Chief Executive Officer and President
1.10m--11.15m-
Dr. Pearl S. Huang, PhD
Independent Director
0.10m--0.32m-
Ms. Jianqing Bennett
Senior Vice President, TA Instruments Division
0.61m--2.52m-
Ms. Heather L. Knight
Independent Director
0.04m--0.13m-
Mr. Robert L. Carpio, III
Senior Vice President, Waters Division
0.28m0.20m-1.95m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc7,272,2520.048461735842.44530430 Apr 202512.22
BlackRock Inc6,940,6510.053734571487.05094130 Apr 202511.67
Fundsmith LLP3,613,1976.06024-21325-0.58673530 Apr 20256.07
Fundsmith Equity Fund3,366,8314.44702--30 Apr 20255.66
AllianceBernstein L.P.2,654,0020.334142123648.69760430 Apr 20254.46

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
31 Dec 2024-Dr. Pearl S. Huang, PhD--2,627--
31 Dec 2024-Mr. Wei Jiang--2,038--
31 Dec 2024-Ms. Heather L. Knight--241--
30 Sep 2024-Dr. Pearl S. Huang, PhD--2,544--
30 Sep 2024-Mr. Wei Jiang--1,958--
30 Sep 2024-Ms. Heather L. Knight--169--
14 Aug 2024-Ms. Heather L. Knight--349--
14 Aug 2024-Ms. Heather L. Knight--136--
28 Jun 2024-Dr. Pearl S. Huang, PhD--2,469--
28 Jun 2024-Mr. Wei Jiang--1,895--
24 Jun 2024-Mr. Robert L. Carpio, III--4,494--
24 Jun 2024-Mr. Robert L. Carpio, III--5,537--
28 May 2024-Mr. Richard H. Fearon332.90332,9001,653--
15 May 2024-Mr. Christopher A. Kuebler361.641,446,56014,716--
15 May 2024-Mr. Christopher A. Kuebler-----
15 May 2024-Mr. Christopher A. Kuebler113.88455,52018,716--
13 May 2024-Mr. Amol Chaubal349.2850,6462,295--
05 Apr 2024-Ms. Jianqing Bennett335.9467,8602,772--
28 Mar 2024-Dr. Pearl S. Huang, PhD--75--
28 Mar 2024-Mr. Wei Jiang328.7220,38162--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.